Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapinarof Cream 1% vs Vtama in Plaque Psoriasis
NCT07546214Phase 1Completed
- Start
- Oct 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tapinarof in plaque psoriasis (3 arms). Primary endpoint: Demonstration in Therapeutic Equivalence & Safety of the Investigational Product at 12 weeks. Started Oct 2025; status: completed.
02
Drugs
tapinarof
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07546214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07546214.